Literature DB >> 7770128

Lethal arthrogryposis in Finland--a clinico-pathological study of 83 cases during thirteen years.

K Vuopala1, J Leisti, R Herva.   

Abstract

Eighty-three cases of multiple congenital joint contractures, i.e., arthrogryposis, which were related with either a stillborn fetus, a termination of pregnancy following prenatal diagnosis or death within 28 days postnatally, were studied. Sixty-seven cases were neurogenic in origin, including forty-one with the lethal congenital contracture syndrome (LCCS, McKusick 253310), fifteen with milder anterior horn cell involvement, and ten with dysgenesis and degeneration of the CNS. Congenital muscular dystrophy was seen in two cases and nemaline myopathy in one case. A non-neuromuscular basis was established in ten cases, and the cause remained obscure in three cases. Apart from the autosomal recessive LCCS, the fifteen cases with anterior horn cell involvement made up a uniform clinico-pathological entity. In two families this disease recurred twice, and autosomal recessive inheritance is therefore likely. Recurrence was also seen twice in a family with central nervous system degeneration and in another with the oligohydramnios sequence. There are apparently several recessively inherited entities among the arthrogryposis phenotype. A careful clinical study and a neuropathological examination are essential for estimating the recurrence risk.

Entities:  

Mesh:

Year:  1994        PMID: 7770128     DOI: 10.1055/s-2008-1073045

Source DB:  PubMed          Journal:  Neuropediatrics        ISSN: 0174-304X            Impact factor:   1.947


  10 in total

Review 1.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

2.  Familial fetal akinesia deformation sequence with a skeletal muscle maturation defect.

Authors:  K Vuopala; F Pedrosa-Domellöf; R Herva; J Leisti; L E Thornell
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

3.  A case of congenital bilateral absence of elbow flexor muscles: review of differential diagnosis and treatment.

Authors:  David T Netscher; Oluseyi Aliu; Saleh Samra; Eric Lewis
Journal:  Hand (N Y)       Date:  2007-10-09

4.  Assignment of the disease locus for lethal congenital contracture syndrome to a restricted region of chromosome 9q34, by genome scan using five affected individuals.

Authors:  P Mäkelä-Bengs; N Järvinen; K Vuopala; A Suomalainen; J Ignatius; M Sipilä; R Herva; A Palotie; L Peltonen
Journal:  Am J Hum Genet       Date:  1998-08       Impact factor: 11.025

5.  Lethal contractural syndrome type 3 (LCCS3) is caused by a mutation in PIP5K1C, which encodes PIPKI gamma of the phophatidylinsitol pathway.

Authors:  Ginat Narkis; Rivka Ofir; Daniella Landau; Esther Manor; Micha Volokita; Relly Hershkowitz; Khalil Elbedour; Ohad S Birk
Journal:  Am J Hum Genet       Date:  2007-07-24       Impact factor: 11.025

6.  Diagnosing arthrogryposis multiplex congenita: a review.

Authors:  Emmanouil Kalampokas; Theodoros Kalampokas; Chrisostomos Sofoudis; Efthymios Deligeoroglou; Dimitrios Botsis
Journal:  ISRN Obstet Gynecol       Date:  2012-09-23

7.  Cervical stenosis in a patient with arthrogryposis: case report.

Authors:  Jerry Du; Alexander Aichmair; Marios Lykissas; Federico Girardi
Journal:  Evid Based Spine Care J       Date:  2014-04

8.  Arthrogryposis: an update on clinical aspects, etiology, and treatment strategies.

Authors:  Bartłomiej Kowalczyk; Jarosław Feluś
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

9.  Arthrogryposis Multiplex Congenita Related to Third-Trimester Basal Ganglia Ischemia: A Case Report.

Authors:  Perrine Venot; Philippe Vo Van; Gratiella Mac Caby; Gauthier Loron; Jean Paul Bory; Ahmad Akhavi; Nathalie Bednarek
Journal:  Child Neurol Open       Date:  2015-02-10

10.  Case Report: Prenatal Diagnosis of Nemaline Myopathy.

Authors:  Dongmei Liu; Jiali Yu; Xin Wang; Yang Yang; Li Yu; Shi Zeng; Ming Zhang; Ganqiong Xu
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.